BIOMAT Database Logo BIOMAT Database Logo

[Determination of the migration inhibition factor in the blood serum and synovial fluid in rheumatic diseases]. 1982

V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ

UI MeSH Term Description Entries
D007961 Leukocyte Migration-Inhibitory Factors Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of LEUKOCYTES, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the LEUKOCYTE MIGRATION CAPILLARY TUBE TECHNIQUE (LMCT) and the LEUKOCYTE MIGRATION AGAROSE TEST (LMAT). Migration-Inhibition Factors, Leukocyte,Leukocyte Migration-Inhibition Factors,Migration-Inhibitory Factors, Leukocyte,Factors, Leukocyte Migration-Inhibition,Factors, Leukocyte Migration-Inhibitory,Leukocyte Migration Inhibition Factors,Leukocyte Migration Inhibitory Factors,Migration Inhibition Factors, Leukocyte,Migration Inhibitory Factors, Leukocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D013585 Synovitis Inflammation of the SYNOVIAL MEMBRANE. Plica Syndrome,Synovial Plica Syndrome,Synovial Hypertrophy,Synovial Thickening,Hypertrophies, Synovial,Hypertrophy, Synovial,Plica Syndrome, Synovial,Synovial Hypertrophies,Synovial Thickenings,Synovitides,Thickening, Synovial,Thickenings, Synovial

Related Publications

V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
Serum and synovial fluid osteocalcin in rheumatic diseases.
January 1992, International journal of clinical pharmacology research,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
Immunoblasts in synovial fluid and blood in the rheumatic diseases.
August 1980, Annals of the rheumatic diseases,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
[Hemolytic complement of the blood and synovial fluid in rheumatic diseases].
January 1975, Revista espanola de reumatismo y enfermedades osteoarticulares,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
[Behavior of complement in serum and synovial fluid in rheumatic diseases].
January 1968, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
[Synovial fluid in various rheumatic diseases].
January 1969, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
Synovial fluid ferritin in rheumatic diseases.
January 1985, Scandinavian journal of rheumatology,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
Free radicals in children with rheumatic diseases in serum and synovial fluid.
January 1991, Acta Universitatis Carolinae. Medica,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
[Study of complement in blood and synovial fluid in various rheumatic diseases].
January 1972, Revista espanola de reumatismo y enfermedades osteoarticulares,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
Serum and synovial fluid antibodies to collagen in rheumatic diseases: a review.
December 1986, Clinical rheumatology,
V I Konenkov, and D G Bogel'man, and V S Shirinskiĭ, and V M Mishin, and V P Lozovoĭ
[Proteolytic enzymes of the synovial fluid in rheumatic diseases].
April 1988, Vrachebnoe delo,
Copied contents to your clipboard!